Belpointe Asset Management LLC Buys 125,094 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Belpointe Asset Management LLC grew its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 648.5% during the second quarter, Holdings Channel reports. The firm owned 144,384 shares of the pharmacy operator’s stock after purchasing an additional 125,094 shares during the period. Belpointe Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $1,746,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Quest Partners LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. 1832 Asset Management L.P. lifted its holdings in shares of Walgreens Boots Alliance by 282.1% in the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 900 shares in the last quarter. New Covenant Trust Company N.A. bought a new position in shares of Walgreens Boots Alliance in the first quarter valued at approximately $35,000. Finally, First Personal Financial Services lifted its holdings in shares of Walgreens Boots Alliance by 260.0% in the first quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 1,300 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $8.65 on Thursday. The stock has a market cap of $7.47 billion, a PE ratio of -1.28, a price-to-earnings-growth ratio of 0.65 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.62 and a fifty-two week high of $27.05. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The stock has a fifty day moving average of $10.89 and a 200-day moving average of $15.78.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The company had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. Walgreens Boots Alliance’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.00 earnings per share. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Wednesday, August 21st will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 11.56%. The ex-dividend date of this dividend is Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is -14.84%.

Wall Street Analyst Weigh In

A number of analysts recently commented on WBA shares. TD Cowen dropped their price target on Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating on the stock in a report on Monday, July 1st. Evercore ISI dropped their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. Bank of America dropped their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday. Barclays dropped their price target on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a report on Tuesday, July 23rd. Finally, Morgan Stanley dropped their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $15.19.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.